TORONTO - Apotex Corp. issued a voluntary recall of ranitidine tablets, a generic form of Zantac meant to treat heartburn, over concerns that the tablets may contain too much of a probable human ...

Recalls of heartburn medication continue with Minnesota-based Appco Pharma voluntarily recalling all quantities, within expiration date, of its ranitidine hydrochloride capsules to the consumer level.

(WAFB) - Updates issued by the U.S. Food and Drug Administration (FDA) Wednesday, Oct. 23 show more products used to relieve and prevent heartburn are being recalled due to the potential presence of ...

A voluntary recall of a generic version of Zantac has been issued because the drug has been found to contain a contaminant that could cause cancer. Sandoz Inc. is recalling 14 lots of prescription ...

Earlier this week, CVS, Rite Aid, and Walgreen’s suspended sales of Zantac (ranitidine) products. This follows the announcement last month by Sandoz, the generics division of Novartis, that it was ...

Appco Pharma LLC (Appco) is voluntarily recalling all quantities and lots, within expiry, of Ranitidine Hydrochloride Capsules to the Consumer level. Ranitidine Hydrochloride Capsules are being ...

A new nationwide recall has been issued for a generic version of the heartburn and ulcer drug Zantac due to the potential presence of an impurity that could cause cancer. It's the fourth recall for ...

More generic versions of Zantac are being pulled from pharmacy shelves after officials discovered low levels of a probable carcinogen in the heartburn drug. The Food and Drug Administration this week ...

Both Appco Pharma and Denton Pharma are voluntarily recalling all unexpired lots of their ranitidine products after finding they contained levels of a human carcinogen. The recalls are the latest in a ...

NEW YORK, July 31 (Praxis Press) Previous studies have shown that omeprazole sodium is more effective than ranitidine hydrochloride in controlling symptoms of heartburn in patients with ...

March 21, 2006 -- The US Food and Drug Administration (FDA) has approved first-time generic formulations of fluticasone propionate 50-µg nasal spray for the management of rhinitis symptoms in patients ...

April 22, 2004 — The U.S. Food and Drug Administration (FDA) has approved insulin glulisine injection for diabetes, triamcinolone acetonide nasal aerosol for allergic rhinitis, abacavir sulfate for ...